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Platinum catalysed hydrosilylation of propargylic
alcohols†
Catherine A. McAdam,a Mark G. McLaughlin,a Adam J. S. Johnston,a Jun Chen,a
Magnus W. Walterb and Matthew J. Cook*a
A facile and user-friendly protocol has been developed for the selective synthesis of E-vinyl silanes
derived from propargylic alcohols using a PtCl2/XPhos catalyst system. The reaction is generally high
yielding and provides a single regioisomer at the β-position with E-alkene geometry. The reaction is extre-
mely tolerant of functionality and has a wide scope of reactivity both in terms of alkynes and silanes
used. The catalyst loading has been investigated and it is found that good reactivity is observed at extre-
mely low catalyst loadings. This methodology has also been extended to a one-pot hydrosilylation
Denmark–Hiyama coupling.
Introduction
Vinyl silanes are useful intermediates which can undergo a
wide range of chemical transformations.1 The use of silanes as
a protecting group for oxygen functionalities is, of course, well
documented, and much interest has focused on their use in
low cost, non-toxic routes to the formation of carbon–carbon
bonds. These include Sakurai allylations,2 fluoride mediated
Hiyama cross-coupling,3 and the fluorine-free Denmark–
Hiyama cross-coupling variation4 and a number of copper
mediated oxygen–carbon silicon migrations have been
reported in the last decade.5 They have also found use in the
formation of carbon–oxygen bonds through Tamao–Fleming
oxidation6 and the development of an epoxidation–oxidation
reaction sequence.7,8
There are many methods for the preparation of vinyl
silanes.9 The most widely used of these methods centre
around the use of either hydrosilylation or other silylmetalla-
tion reactions. The majority of existing methods do not toler-
ate the incorporation of further functionality in either the
substrate or the silane used, thus severely limiting their utility
in synthesis. Such methods include the use of silylcuprates,
developed by Fleming and later modified by Lipshutz, with
each isomer of the vinyl silane being formed selectively by
altering the nature of the Cu(I) species involved.10–13 Organo-
chromium species have proven to be of great use in the for-
mation of vinyl silanes from aldehydes, which react selectively
over ketones.14–17 Further molecular complexity of these sub-
strates can be achieved through Mizoroki–Heck type cross-
coupling reactions18 and Peterson olefinations.19
The hydrosilylation of alkynes is a powerful method of
forming vinyl silanes in a stereocontrolled manner.9,20 There
are many catalysts that promote this reaction and late tran-
sition metal catalysts have been shown to be especially
eﬃcient.21,22 There are two regioisomeric products alongside
E/Z isomers available in this reaction. In the case of pro-
pargylic alcohols the two regioisomers are referred to as the α
and the β-isomers where the silyl group is located α and β to
the alcohol and aﬀords 1,1 or 1,2-substituted vinyl silanes,
respectively (eqn (1)).
ð1Þ
Ruthenium complexes are especially eﬃcient at producing
the internal α-isomer with high selectivity. Trost and co-
workers have investigated this reaction extensively, firstly using
a cyclopentadienyl ruthenium complex to perform the desired
hydrosilylation with moderate stereoselectivity.22 Further inves-
tigation led to the development of a highly active and selective
cationic catalyst, [Cp*Ru(MeCN)3]PF6, which gives the α-vinyl-
silane in a >20 : 1 ratio.23 The Lewis acid catalysed hydrosilyl-
ation of a range of alkynes with diverse functionality, as
developed by Yamamoto,24–27 also aﬀords the α-isomer as a
single product, although this method is still in its infancy.
†Electronic supplementary information (ESI) available: Details of starting
material synthesis and spectra of the compounds reported (1H and 13C NMR) are
included. See DOI: 10.1039/c3ob40496j
aSchool of Chemistry and Chemical Engineering, Queen’s University Belfast, Belfast,
BT9 5AG Northern Ireland, UK. E-mail: m.cook@qub.ac.uk;
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The majority of transition metal catalysed hydrosilylation
reactions give the β-isomer as the major product.28,29 Metals
such as rhodium,30–35 ruthenium36–38 and titanium39 have
proven useful. Platinum complexes are by far the most well
developed catalysts for the hydrosilylation of alkynes, aﬀording
the β-isomer, in the E-geometry as the major product.21,40
Complexes such as Speier’s catalyst [H2PtCl6] and Karstedt’s
catalyst [Pt2(dvs)3] (dvs = 1,3-divinyl-1,1,3,3-tetramethyldisil-
oxane) can produce high catalyst turnovers; however, both the
regio and E/Z selectivity can be poor.41–43
A solution to this problem was found through the use of bulky
trialkylphosphine ligands44–47 and more recently the use of
platinum N-heterocyclic carbene complexes.48–52 These steri-
cally encumbered catalysts can impart high levels of selectivity
on the reactions. Of note was the development of the (dvs)Pt-
Pt-Bu3 catalyst which exhibits excellent catalytic activity and a
high level of selectivity. The drawbacks to these methods are
the cost of the Pt(0) precatalysts and the pyrophoric nature of
the phosphines required.
Alami reported that a combination of Pt(II) salts and bulky di-
alkylarylphosphines,53 such as XPhos, catalysed the hydrosilyl-
ation of alkynes, with one example of propargyl alcohol itself
reported.54 The reaction proceeded in good yields and excel-
lent selectivities; however, a large catalyst loading is required,
typically 5 mol% Pt and 10 mol% phosphine.
We required a rapid and reliable method for the synthesis
of β-silyl alyllic alcohols that was tolerant of significant steric
encumbrance.55 Panek previously disclosed the use of the
highly reactive (dvs)Pt-Pt-Bu3 catalyst for the regioselective
hydrosilylation of propargylic alcohols;56,57 however, no
examples of sterically congested or tertiary propargylic alco-
hols were reported. We speculated that we could modify the
reaction reported by Alami to combine the catalytic activity of
the bulky Pt(0) catalyst with the selectivity and operational
ease of the air stable Pt(II) system. We discovered that the
PtCl2/XPhos catalyst system was very eﬃcient for propargylic
alcohols vida infra.58 Under these conditions the catalyst
loading could be lowered to 1 mol% and 0.5 mol% platinum(II)
chloride for the secondary and tertiary propargylic alcohols,
respectively.
Herein we report a full investigation into the scope and
limits of these hydrosilylation reactions including the use of
highly functionalised substrates.
Results and discussion
Optimisation of Pt catalysed hydrosilylation
We began investigating the hydrosilylation of commercially
available but-3-yn-2-ol (Table 1). Using 5 mol% PtCl2 and
10 mol% XPhos the reaction aﬀorded the vinyl silane as a
single regio- and geometric isomer in excellent yield (entry 1).
When the reaction was carried out in the absence of ligand,
the regioselectivity fell to 9 : 1 (entry 2). Further optimisation
of the transformation led to a reduction of the amount of cata-
lyst needed, and at 1 mol% PtCl2 excellent yields were still
being obtained (entry 4). If the catalyst loading is dropped
further, the reaction becomes sluggish and lower yields are
obtained (entry 5). The amount of silane can also be reduced,
but once again a noticeable slowing of the reaction is observed
(entry 6).
Hydrosilylation of secondary propargylic alcohols
With the optimised reaction conditions in hand, we began by
examining the scope of the reaction using secondary propargyl
alcohols (Table 2). We soon discovered that propargyl alcohol
itself was a very poor substrate for this reaction with only 47%
yield of the vinyl silane 2a being produced. Contrary to this, a
wide range of alkyl substituents were well tolerated, including
linear 2b–c and branched groups 2d–e all providing good
yields of the corresponding hydrosilylated product. Our atten-
tion then turned to vinyl and aryl substituents. A styrenyl
derivative 2f was well tolerated as were many aromatic groups
2g–l even including aryl groups bearing ortho-substituents 2m
that are tolerated albeit in a reduced yield. We also examined
heterocycles 2n–q, especially those containing basic nitrogen
atoms to test whether these would inhibit the catalyst. Gratify-
ingly, these were all good substrates providing the requisite
Table 1 Optimisation studies
Entry mol% PtCl2/XPhos Equiv. R3SiH β : α ratioa Yieldb (%)
1 5/10 1.6 >99.1 93
2 5/10 1.6 >91.9 72
3 2/4 1.5 >99.1 93
4 1/2 1.5 >99.1 91
5 0.5/1 1.5 >99.1 74
6 1/2 1.1 >99.1 83
aDetermined by 1H NMR of the crude. b Isolated yield of the pure
isomer.
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vinyl silane in moderate to high yields in all cases. In general
these heterocyclic substrates aﬀorded slightly lower yields and
required prolonged reaction times compared to their less func-
tionalised counterparts. When the hydrosilylation was
attempted using the ortho-chloroaryl derivative 1r, no reaction
was observed. Both increasing the reaction time and the cata-
lyst loading did not aﬀord any product, with starting material
recovered in each case. This class of substrate is the only one
we have found so far to be ineﬀective for this reaction.
Hydrosilylation of tertiary propargylic alcohols
We next turned our attention to tertiary propargylic alcohols as
prior to our original communication the hydrosilylation of hin-
dered propargylic alcohols was not widely reported except in
the presence of non-commercial specialist ligands.59 We found
that the PtCl2/XPhos system was especially eﬃcient for the
hydrosilylation of tertiary propargylic alcohols and that
0.5 mol% of PtCl2 could be used to give excellent yields. We
have further expanded the scope of the reaction and found
that it is tolerant of a wide range of functional groups
(Table 3).
We began by examining simple alkyl substituents 4a–c and
found that these underwent the hydrosilylation reaction in
excellent yields. Similarly, aryl substituents, both with one and
two aryl groups 4d–f, were tolerated. Fluoroalkyl groups could
be included in 4g as could heterocycles, with thiophene 4h
substituents easily incorporated. Our attention then turned to
cyclic tertiary propargylic alcohols. A wide range of cyclic alkyl
substituents were addressed in this reaction, all of which pro-
ceeded in good to excellent yields 4i–n. Substituents on these
carbocycles were also tolerated with a difluoromethylene and
ketal groups 4o–p, alongside fused aromatics 4q–r being
installed with little eﬀect on the yields of the reaction. Finally
we examined heterocyclic substrates, with nitrogen containing
heterocycles performing well in this reaction, including azeti-
dines 4s, piperidines 4t and even tropanes 4u to aﬀord good
yields of vinyl silanes, albeit with a substantial increase in the
required reaction time. Chalcogen containing heterocycles 4v–w
were also examined, with the reaction proceeding in a similar
fashion to their carbocyclic analogues providing the corres-
ponding vinyl silanes in good to excellent yields.
Catalyst loading studies
As the reaction is highly eﬃcient for tertiary propargylic alco-
hols, using just 0.5 mol% catalyst loading, we examined the
eﬀect of further reducing the amount of catalyst and whether
this would have a negative eﬀect on the reaction (Table 4).
Halving the catalyst loading to 0.25 mol% proved to have very
little eﬀect on the reaction and further reductions showed that
this system still gave synthetically useful yields when dropped
to as low as 0.05 mol%. Further reductions, to 0.025 and
0.01 mol%, were possible; however, the reaction slows signifi-
cantly. A prolonged reaction time appears to counteract this to
some degree, leading to the conclusion that the catalyst is
stable for extended periods of time; hence, further reductions
in catalyst loading could be possible if required. A TON of 6900
Table 2 Secondary propargylic alcohols
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was achieved which shows the catalyst’s stability and applica-
bility. It is diﬃcult to directly compare to other catalysts as our
studies were performed using PhMe2SiH and most other
hydrosilylation catalysts are tested against Et3SiH as a stan-
dard. In general, Et3SiH is a more reactive silane with TONs of
around 70 000 being achieved in certain cases.59 Our catalyst
system does, however, benefit from excellent stability and func-
tional group tolerance, making it a very practical method.
Use of other silanes
As all of the examples shown in Tables 1–4 utilised phenyldi-
methylsilane, we then began examining the use of other com-
mercially available silanes. We found that the reaction is
tolerant of a wide range of silanes, with the triethylsilyl 5a,
Table 3 Tertiary propargylic alcohols
Table 4 Catalyst loading studies
Entry Pt loading Time (h) Yielda
1 0.5 mol% 16 94%
2 0.25 mol% 16 93%
3 0.1 mol% 16 83%
4 0.05 mol% 16 81%
5 0.025 mol% 40 73%
6 0.01 mol% 90 69%
a Isolated yield of a single isomer.
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tert-butyldimethylsilyl 5c, benzyldimethylsilyl 5d triphenylsilyl
5e and triethoxysilyl 5f derivatives formed in good yields.
When tri-iso-propylsilane was used no reaction was observed
with quantitative recovery of starting material. Presumably the
increased steric bulk of the silane prevents the reaction from
occurring. Interestingly when diphenyl silane and phenylsilane
were used, two or three sequential hydrosilylations could be
carried out on the same silicon atom, forming dimers and
trimers of the propargylic alcohols (Table 5).60
Our attention next turned to the hydrosilylation using bis-
(dimethylsiloxane) to allow subsequent Hiyama couplings.
Unfortunately this aﬀorded poor isolated yields, although
there was complete conversion to the vinylsilane from analysis
of the crude reaction mixture suggesting that the product 5h
was unstable for silica gel chromatography. To circumvent this
issue, a one-pot Denmark–Hiyama coupling was attempted.61
The hydrosilylation occurred in good conversion using the
standard conditions and then simply cooling the reaction,
adding TBAF followed by Pd2dba3 and iodobenzene aﬀorded a
very facile cross-coupling which gave 72% yield after just
10 minutes (eqn (2)).
ð2Þ
Internal alkynes
We also examined internal alkynes to investigate whether the
Lewis basic oxygen atom was co-ordinating to the metal and
directing the addition62 or whether the regioselectivity was
based purely on steric factors. The first substrate attempted
was but-2-yn-1-ol 7, which gave a 1 : 1 mixture of regioisomers
(eqn (3)). This clearly suggests that the oxygen is not directing
the addition and that pure sterics govern the regioselectivity.
This also demonstrates that primary propargylic alcohols can
participate well in this reaction when extra substitution is
present at the β-position as an overall yield of 84% was
obtained. When steric bulk is increased in the propargylic
position the ratio increases to give moderate β selectivity. Alkyl
groups give around 3 : 1 selectivity with methyl 9 aﬀording
2.7 : 1 β : α, butyl 11 3.2 : 1 and when a cyclohexyl group 13 is
introduced a β-selectivity of 3.2 : 1 was observed (eqn (4)–(6)).
This is in line with what one would expect based on the steric
environment of the alkyne.
When the terminal alkyne position of propargyl alcohol was
substituted with a phenyl group 15, modest selectivity was
observed with the β-isomer 16a prevailing in a 4.1 : 1 ratio (eqn (7)).
This is contrary to the steric environment around the alkyne
and is clearly showing preference for hydride attack at the
more electrophilic terminus of the alkyne.23,47,63,64 Indeed,
Alami observed this eﬀect when applied to the palladium cata-
lyzed hydrostannylation of 13, with 4 : 1 regioselectivity for
β-substitution being observed.65 They also showed that the
regioselectivity in these systems directly correlated to the
Hammett σ-value for substituted benzene rings. When strong
electron withdrawing groups were present in the para-position
of the benzene ring a single β-regioisomer was obtained
whereas electron releasing groups produce selectivities of the
order of a 3 : 1 β : α ratio.
Similarly when a trimethylsilyl group is installed at the
β-position 17, the product ratio is contrary to the steric
environment (eqn (8)). The mild polarisation of the alkyne
group caused by the silane is enough to override the signifi-
cant steric bias to aﬀord the β-regioisomer 18a as the major
product. If the steric environment at the β-position is
increased greatly by installing a tert-butyl group 19, the regio-
selectivity of the reaction can be switched to give solely the
α-isomer. No traces of the β-isomer 20a were observed with
only the α-isomer 20b being formed in good yield (eqn (9)). A
single regioisomer could again be obtained when the pro-
pargylic position was highly substituted compared to the
β-position 21. In this instance only the β-isomer 20a was
observed again in good yield (eqn (10)). The results in eqn (9)
and (10) demonstrate that the steric environment around the
alkyne plays a pivotal role in determining the selectivity of the
products. However, when the alkyne is polarised and an
Table 5 Other silanes
a Using 0.5 equivalent of Ph2SiH2.
b Using 0.3 equivalent of PhSiH3.
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electronic bias is present, such as eqn (7) and (8), the regio-
chemistry will be dictated by the attack of the hydridic hydro-
gen at the more electron deficient terminus.
ð3Þ
ð4Þ
ð5Þ
ð6Þ
ð7Þ
ð8Þ
ð9Þ
ð10Þ
Similarly, when a trimethylsilyl substituted alkyne was used
the hydrosilylation gave a 2.2 : 1 mixture of β : α isomers. The
reaction proceeds to give a diﬀerentially substituted 1,1-vinyl-
disilane. Again the polarising eﬀect of the silane can rational-
ise the regiochemical outcome as the β position is more
electrophilic than the α.
Mechanistic insights
Fig. 1 highlights our model for regioselectivity. In the cases
where there is a steric bias, the large group orientates itself
away from the bulky XPhos ligand. The result of this is the
selective formation of a product with the hydrogen adjacent to
the large group and the silyl group next to the smaller group.
In the case of the electronically biased substrates, the phenyl
or silyl group creates a polarised alkyne and the hydridic
hydrogen on the platinum adds at the more electrophilic ter-
minus thus resulting in the hydrogen adjacent to the less elec-
tron withdrawing group and the silyl group next to the electron
withdrawing substituent. This polarisation appears to be sig-
nificant enough to override the inherent steric bias for one
product over the other.
We conducted a competition experiment between propargyl
alcohol 1a, but-3-yn-2-ol 1b, and 2-methyl but-3-yn-2-ol 3a
where the reaction was conducted with one equivalent of each
of the substrates and one equivalent of PhMe2SiH to ascertain
the relative rate of reactions. As expected the tertiary alcohol
reacted faster than the secondary which in turn was faster
than the primary in a krel of 2.7 : 1.7 : 1. This proves that the
enhanced reactivity observed for tertiary propargylic alcohols
is due to an inherently faster reaction rate rather than factors
such as product inhibition or catalyst decomposition
(Scheme 1).
We next examined whether the incorporation of deuterium
at the terminal position of the alkyne led to an observable
kinetic isotope eﬀect. Alkyne 23 was readily prepared and was
subjected to competition experiment with its non-deuterated
analogue. Following conversion to 49%, the product 4k/24 was
protioenriched alongside the recovered starting material being
deuteroenriched in the same ratio. Both recovered starting
material and product conversion gave a kH/kD value of 1.44.
This suggests a large secondary kinetic isotope eﬀect consist-
ent with a change in geometry from sp to sp2 during the rate
limiting step (Scheme 2).66
We observed significant evolution of gas, presumably
hydrogen, upon addition of the silane to the reaction mixture.
This led us to examine the origin of this gas. There are several
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possible explanations including: the simple reduction of the Pt(II)
salt to Pt(0) producing H2 and a disilane or the OH bond
reacting directly with the catalyst producing a Pt(OR) type
complex. To probe the eﬀect the O–H bond may have on the
reactivity of this reaction a series of experiments were con-
ducted. Firstly we performed a control experiment with benzyl
alcohol to determine whether any O-silylation was observed
during the reaction (eqn (11)). No reaction or O-silylation was
observed with quantitative recovery of the starting material
being achieved.
ð11Þ
We next investigated the use of the methyl ether 27 and
found that the hydrosilylation occurred in a similar overall
yield to the hydroxyl analogue 28 (eqn (12)). This suggests
that the OH is not required for reactivity and to obtain high
yields.
ð12Þ
Fig. 1 Origin of regioselectivity.
Scheme 1 Primary/secondary/tertiary competition experiment.
Scheme 2 Alkyne kinetic isotope eﬀect.
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A competition experiment was conducted between the OH
and OMe compounds to elucidate the relative rates of the reac-
tions. The OH compound 3k reacted much faster than the
OMe analogue 27 with a krel of 2.3 being observed, suggesting
that the OH does accelerate the reaction (Scheme 3).
To further probe this eﬀect, we prepared the O-deuterated
analogue and subjected this to the reaction conditions. Again
the reaction proceeded with a similar overall yield and with no
deuterium incorporated into the resultant alkene (eqn (13)).
This suggests that the formation of Pt(OR) complexes is unli-
kely as deuterium would also be delivered to the platinum
catalyst which would in turn be observed in the vinyl silane
product.
ð13Þ
Finally, we examined whether there was a OH/OD kinetic
isotope eﬀect which would elucidate the true role of the
alcohol moiety. As this is an exchangeable deuterium measur-
ing the product or recovered starting material, deuterium
enrichment would be diﬃcult. We therefore took two alkynes,
the dimethyl substrate 3a and the cyclohexyl derivative 3k. We
first of all performed a control experiment where we measured
the relative rate of reactions between the two compounds. The
cyclohexyl analogue was found to have a faster rate of reaction
with a krel (3k : 3a) of 1.24 and this was used as a correction
factor in the kinetic isotope eﬀect calculations. When the
reaction was performed using equimolar amounts of 3k and
d1-3a, which was formed in 86% isotopic purity,
67 the order of
reactivity was reversed with the dimethyl compound reacting
at a faster rate. As the alcohol was only deuterated to 86% we
had to adjust this value to 100% isotopic purity assuming a
linear relationship and found a krel (3k : d1-3a) of 0.86. This
was then used to measure the kinetic isotope eﬀect which
equated to 0.69 (Scheme 4).
An inverse kinetic isotope eﬀect could be due to several
factors, including a pre-equilibrium; however, the absence of
deuterium in the vinyl silane and the rapid evolution of
hydrogen gas make this unlikely. A more likely scenario is
the OH moiety hydrogen bonding to the hydridic hydrogen
bound to the platinum centre and accelerating the hydrome-
tallation step through mild acid catalysis. Indeed, this is con-
sistent with the hydrometallation step being rate limiting.
This can be seen in Fig. 2 where the OD/OH group can
H-bond to the hydridic hydrogen, thus weakening the Pt–H
bond and accelerating the reaction. This interaction does
explain the rate acceleration; however, one would predict
some regioselectivity based on this, which is not seen in the
case of internal alkynes. Either this chelate is not possible
in the internal cases or this occurs in an intermolecular
fashion.
More sterically hindered substrates react much faster in
this reaction and we sought to rationalise this mechanistically.
In the standard Chalk–Harrod mechanism28 for hydrosilyl-
ation of alkynes, there are two events that can occur to lead to
product (Fig. 3): either oxidative addition of the silane followed
by alkyne coordination (Pathway 1) or alkyne coordination fol-
lowed by oxidative addition (Pathway 2). Pathway 1 would
favour relatively small alkynes as the coordination event occurs
on a sterically congested Pt(II) species C. These types of sub-
strates are excellent with Speier’s catalyst and Karstedt’s
catalyst.
Scheme 3 Role of the OH bond.
Scheme 4 OH kinetic isotope eﬀects.
Fig. 2 Possible H-bond acceleration of hydrometallation.
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Our results suggest that Pathway 2 is operating as the major
pathway as more hindered substrates are superior. A large alkyne
can bind to the coordinatively unsaturated Pt(0) species B thus
stabilising this prior to oxidative addition. Alternatively, if a
small alkyne is bound to the coordinately unsaturated platinum–
ligand complex F, a second alkyne can then bind, thus removing
the coordination sites needed for the oxidative addition reaction.
The result is that the catalyst is removed from the productive
cycle I and the rate of reaction is based on the decomplexation
of the second alkyne. When a bulky alkyne is used the complex-
ation of two substrates is disfavoured, thus leaving the catalytically
active species available for subsequent oxidative addition to
form G, migratory insertion H and reductive elimination. This
is very clearly demonstrated in the case of propargyl alcohol 1a.
Our experiments suggest that the migratory insertion event
is rate limiting with a large sp–sp2 secondary kinetic isotope
eﬀect being observed. This could occur from G or an isomeri-
sation event to D could occur due to the large trans-eﬀect of
both silanes and hydrides. Both complexes would give a
similar result in terms of kinetic isotope eﬀects and therefore
cannot be distinguished.
It is also possible that the silane can react directly with F in
a concerted manner to proceed directly to H with the same
factors that would govern reactivity as in the two-step com-
plexation migratory insertion process.
Conclusions
We have shown the eﬀectiveness and robustness of PtCl2/
XPhos catalysed hydrosilylation. Both secondary and tertiary
propargyl alcohols perform well as do internal alkynes. Fur-
thermore, the catalyst system is tolerant of various silanes
which improves the usefulness of this protocol. A one-pot
Hiyama–Denmark cross-coupling reaction was also performed
using the catalyst system which allows access to a range of
functionalities. We have examined the use of internal alkynes
and have found that this is governed by both steric and elec-
tronic factors.
Experimental section
Compounds 2a–2g, 2o, 4a–4d, 4e, 4j–4k and 4v were fully
characterised and reported previously.58 For the synthesis of
the starting alkynes see the ESI.†
General methods
All reactions were carried out under an atmosphere of argon in
oven-dried glassware with magnetic stirring. All reactions were
monitored by thin layer chromatography (TLC) using Merck
TLC silica gel 60 sheets, which were visualised with ultraviolet
Fig. 3 Proposed catalytic cycle.
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light and then developed with iodine and basic potassium per-
manganate solution. Flash chromatography was performed on
Sigma-Aldrich silica gel 60 as the stationary phase and the sol-
vents employed were of analytical grade. 1H NMR spectra were
recorded on a Bruker AVX400 (400 MHz) spectrometer at
ambient temperature. Data are reported as follows: chemical
shift in parts per million (δ, ppm) from deuterated chloroform
(CDCl3) taken as 7.26 ppm, integration, multiplicity (s =
singlet; d = doublet; t = triplet; dd = double doublets; m = mul-
tiplet), and coupling constant (Hz). 13C NMR spectra were
recorded on a Bruker AVX400 (100 MHz) spectrometer. Chemi-
cal shifts are reported in ppm from CDCl3 taken as 77.0 ppm.
Infrared spectra were recorded on a Perkin Elmer RX I FT-IR
spectrometer as liquid films or as dilute solutions between two
KBr discs. Mass spectra were recorded on either a Micromass
GCT Premier or a Waters Micromass LCT Premier spectro-
meter using electron ionisation (EI) at 70 eV or electrospray
(ES) techniques, respectively. Unless stated otherwise, all com-
mercially available reagents were used as received. When
necessary, commonly used organic solvents were dried prior to
use according to standard laboratory practices.
General procedure A: hydrosilylation secondary propargyl
alcohols
To an oven dried 5 mL round bottom flask equipped with a
reflux condenser and magnetic stirrer was added PtCl2 (1 mol%)
and 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (2 mol%)
(XPhos). The flask was then flushed quickly with argon
and dry THF was added. The mixture was then stirred at 50 °C
for 20 minutes until a yellow homogeneous mixture was
obtained. The corresponding propargyl alcohol (1 eq.) was
added followed by the silane (1.1 equivalents) via syringe
(CAUTION: Rapid evolution of hydrogen gas) and the solution
was stirred at 50 °C overnight. The solvent was evaporated and
the crude mixture was applied to the top of a column and chro-
matographed to aﬀord the requisite (E)-vinyl silane.
(E)-3-(Dimethyl(phenyl)silyl)-1-(p-tolyl)prop-2-en-1-ol (2h). The
title compound was prepared according to general procedure A
from 1-(p-tolyl)prop-2-yn-1-ol68 1h (990 mg, 6.77 mmol) and
dimethylphenylsilane (1.38 g, 10.2 mmol) using PtCl2
(18.0 mg, 0.0677 mmol) and XPhos (64.3 mg, 0.135 mmol) in
THF (2 mL), which following the conversion to the vinyl silane
and column chromatography (9 : 1 hexane–EtOAc) aﬀorded 2h
(1.38 g, 72%) as a colourless oil.
Rf (9 : 1 hexane–EtOAc) = 0.29; νmax (thin film)/cm
−1; 3001,
3068, 2956, 1619, 1427, 248, 1114, 842, 822, 730, 699; 1H NMR:
(400 MHz, CDCl3) δ 7.53–7.48 (2H, m), 7.37–7.32 (3H, m),
7.25–7.21 (2H, m), 7.18–7.13 (2H, m), 6.28 (1H, m), 6.12 (1H,
dt, J = 18.8, 1.28 Hz), 5.17 (1H, t, J = 4.3 Hz), 2.43 (3H, s), 1.96
(1H, m), 0.35 (3H, d, J = 2.0 Hz), 0.34 (3H, d, J = 2.0 Hz); 13C
NMR (100 MHz, CDCl3) δ 149.0, 139.5, 138.4, 137.5, 133.7,
129.3, 129.0, 127.8, 127.2, 126.5, 76.5, 21.1, −2.65; HRMS (ES+)
calcd for C18H22OSiNa [M + Na]
+ 305.1330. Found 305.1338.
(E)-3-(Dimethyl(phenyl)silyl)-1-(naphthalen-2-yl)prop-2-en-1-
ol (2i). The title compound was prepared according to general
procedure A, from 1-(naphthalen-2-yl)prop-2-yn-1-ol68 1i
(500 mg, 2.71 mmol) and dimethylphenylsilane (552 mg,
4.07 mmol) using PtCl2 (7.0 mg, 0.0263 mmol) and XPhos
(25.6 mg, 0.0537 mmol) in THF (1 mL) which following the
conversion to the vinyl silane and column chromatography
(9 : 1 hexane–EtOAc) aﬀorded 2i (660.6 mg, 77%) as a colour-
less solid.
Rf (9 : 1 hexane–EtOAc) = 0.41; νmax (thin film)/cm
−1; 3434,
1634, 1247, 1114, 730.8, 699.4; 1H NMR: (400 MHz, CDCl3) δ
7.88–7.83 (4H, m), 7.58–7.47 (5H, m), 7.40–7.36 (3H, m), 6.39
(1H, dd, J = 18.6, 5.0 Hz), 6.22 (1H, dd, J = 18.8, 1.5 Hz), 5.41
(1H, t, J = 4.0 Hz), 2.18 (1H, s), 0.39 (3H, s), 0.39 (3H, s); 13C
NMR (100 MHz, CDCl3) δ 148.9, 139.8, 138.4, 133.9, 133.4,
133.1, 129.1, 128.5, 128.1, 128.0, 127.9, 127.7, 126.2, 126.0,
125.2, 124.5, 76.9, −2.6; HRMS (EI) calcd for C21H23OSi [M +
H]+ 319.1518. Found 319.1513.
(E)-3-(Dimethyl(phenyl)silyl)-1-(4-methoxyphenyl)prop-2-en-
1-ol (2j). The title compound was prepared according to
general procedure A, from 1-(4-methoxyphenyl)prop-2-yn-1-ol68
1j (500 mg, 3.08 mmol) and dimethylphenylsilane (631 mg,
4.64 mmol) using PtCl2 (8.2 mg, 0.0308 mmol) and XPhos
(29.4 mg, 0.0616 mmol) in THF (1 mL) which following the
conversion to the vinyl silane and column chromatography
(9 : 1 hexane–EtOAc) aﬀorded 2j (643 mg, 70%) as a clear oil.
Rf (9 : 1 hexane–EtOAc) = 0.29; νmax (thin film)/cm
−1; 3412,
2955, 1612, 1512, 1247, 828; 1H NMR: (400 MHz, CDCl3) δ
7.55–7.50 (2H, m), 7.38–7.35 (3H, m), 7.31–7.27 (2H, m)
6.92–6.89 (2H, m), 6.30 (1H, dd, J = 18.6, 4.8 Hz), 6.14 (1H, dd,
J = 18.8, 1.5 Hz), 5.19 (1H, t, J = 3.52 Hz), 3.82, (3H, s), 1.95
(1H, d, J = 4.0 Hz), 0.37 (3H, s) 0.37 (3H, s); 13C NMR
(100 MHz, CDCl3) δ 159.2, 149.1, 138.4, 134.7, 133.8, 129.0,
127.9, 127.8, 114.0, 76.3, 55.3, −2.6; HRMS (EI) calcd for
C18H21O2Si [M − H]+ 297.1311. Found 297.1321.
(E)-3-(Dimethyl(phenyl)silyl)-1-(4-fluorophenyl)prop-2-en-1-
ol (2k). The title compound was prepared according to general
procedure A, from 1-(4-fluorophenyl)prop-2-yn-1-ol69 1k
(350 mg, 2.33 mmol) and dimethylphenylsilane (473 mg,
3.50 mmol) using PtCl2 (6.2 mg, 0.0233 mmol) and
XPhos (22.2 mg, 0.0466 mmol) in THF (1 mL) which
following the conversion to the vinyl silane and column
chromatography (9 : 1 hexane–EtOAc) aﬀorded 2k (501 mg,
75%) as a clear oil.
Rf (9 : 1 hexane–EtOAc) = 0.30 νmax (thin film)/cm
−1; 3350,
2956, 1604, 1508, 1223, 838; 1H NMR: (400 MHz, CDCl3) δ
7.55–7.50 (2H, m), 7.40–7.30 (5H, m), 7.09–7.03 (2H, m), 6.28
(1H, dd, J = 18.6, 4.8 Hz), 6.14 (1H, dd, J = 18.6, 1.3 Hz), 5.22
(1H, d, J = 4.5 Hz), 2.07 (1H, s), 0.39 (3H, s), 0.38 (3H, s) 13C
NMR (100 MHz, CDCl3) δ 162.3 (d,
1JC–F = 244.3 Hz), 158.7,
138.2, 138.1 (d, 4JC–F = 3.3 Hz), 133.8, 129.1, 128.1 (d,
3JC–F =
8.3 Hz), 127.9, 127.8, 115.4 (d, 2JC–F = 21.1 Hz), 76.1, −2.7;
HRMS (EI) calcd for C17H17SiF [M − H2O]+ 268.1084. Found
268.1103.
(E)-3-(Dimethyl(phenyl)silyl)-1-(3-fluorophenyl)prop-2-en-1-
ol (2l). The title compound was prepared according to general
procedure A, from 1-(3-fluorophenyl)prop-2-yn-1-ol 1l (930 mg,
6.18 mmol) and dimethylphenylsilane (1.22 g, 9.27 mmol)
using PtCl2 (16.4 mg, 0.0618 mmol) and XPhos (63.3 mg,
Organic & Biomolecular Chemistry Paper
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0.133 mmol) in THF (5 mL) which following the conversion to
the vinyl silane and column chromatography (9 : 1 hexane–
EtOAc) aﬀorded 2l (1.31 g, 79%) as a colourless oil.
Rf (9 : 1 hexane–EtOAc) = 0.33; νmax (thin film)/cm
−1; 3391,
3069, 2957, 1613, 1591, 1486, 1449, 1428, 1249, 1115, 844, 699;
1H NMR: (400 MHz, CDCl3) δ 7.55–7.49 (2H, m), 7.43–7.30 (4H,
m), 7.16–7.08 (2H, m) 7.02–6.96 (1H, m), 6.26 (1H, dd, J = 18.8,
5.0 Hz), 6.15 (1H, dd, J = 18.8, 1.2 Hz), 5.23 (1H, t, J = 5.08 Hz),
2.09 (1H, d, J = 4.0 Hz), 0.38 (3H, s), 0.38 (3H, s); 13C NMR
(100 MHz, CDCl3) δ 163.0 (d,
1JC–F = 245.6 Hz), 148.2, 145.0 (d,
3JC–F = 6.6 Hz), 138.1, 133.8, 133.0, 130.0, (d,
3JC–F = 8.4 Hz),
129.1, 128.5, 127.8, 122.0, 121.9, 114.5 (d, 2JC–F = 21.1 Hz),
113.2 (d, 2JC–F = 21.9 Hz), 76.2 (d,
4JC–F = 1.8 Hz), −2.7; HRMS
(ES+) calcd for C17H19OFNaSi [M + Na]
+ 309.1087. Found
309.1085.
(E)-3-(Dimethyl(phenyl)silyl)-1-(o-tolyl)prop-2-en-1-ol (2m). The
title compound was prepared according to general procedure
A, from 1-(o-tolyl)prop-2-yn-1-ol68,70 1m (102 mg, 0.721 mmol)
and dimethylphenylsilane (108 mg, 0.793 mmol) using PtCl2
(1.9 mg, 7.21 μmol) and XPhos (6.9 mg, 14.4 μmol) in THF
(0.75 mL) which following the conversion to the vinyl silane
and column chromatography (9 : 1 hexane–EtOAc) aﬀorded 2m
(109 mg, 56%) as a colourless oil.
Rf (9 : 1 hexane–EtOAc) = 0.32; νmax (thin film)/cm
−1; 3069,
3001, 2954, 1628, 1427, 1114, 842, 830, 738, 699; 1H NMR:
(400 MHz, CDCl3) δ 7.53–7.46 (2H, m), 7.41–7.32 (3H, m),
7.23–7.18 (2H, m), 7.17–7.13 (2H, m), 6.27 (1H, dd, J = 18.6, 4.8 Hz),
6.11 (1H, dd, J = 18.6, 4.8 Hz), 5.42 (1H, dt, J = 18.8, 1.28 Hz),
2.35 (3H, s), 0.35 (3H, s), 0.34 (3H, s); 13C NMR (100 MHz,
CDCl3) δ 148.4, 134.7, 133.8, 133.0, 130.6, 130.3, 129.7, 128.9,
127.8, 126.6, 73.6, 72.9, 32.1, 19.2, 11.7, −2.6; HRMS (ES+)
calcd for C18H22OSi [M]
+ 282.1493. Found 282.1440.
(E)-3-(Dimethyl(phenyl)silyl)-1-(pyridin-3-yl)prop-2-en-1-ol
(2n). The title compound was prepared according to general
procedure A, from 1-(pyridin-3-yl)prop-2-yn-1-ol 1n71 (257 mg,
1.9 mmol) and dimethylphenylsilane (284 mg, 2.09 mmol)
using PtCl2 (5.1 mg, 19.2 μmol) and XPhos (18.4 mg,
38.7 μmol) in THF (0.75 mL) which following the conversion to
the vinyl silane and column chromatography (3 : 2 hexane–
EtOAc) aﬀorded 2n (271 mg, 53%) as a yellow oil.
Rf (9 : 1 hexane–EtOAc) = 0.35; νmax (thin film)/cm
−1; 3290,
2853, 2114, 1581, 1427, 1248, 1041, 1028, 947, 823, 710, 634;
1H NMR: (400 MHz, CDCl3) δ 7.94–7.90 (2H, m), 7.72–7.69 (1H,
m), 7.51–7.47 (2H, m), 7.37–7.30 (4H, m), 6.25 (1H, dd, J =
18.6, 4.8 Hz), 6.17 (1H, dd, J = 18.6, 1.1 Hz), 5.27 (1H, d, J = 4.8 Hz),
1.43 (1H, s), 0.35 (3H, s), 0.35 (3H, s) 13C NMR (100 MHz,
CDCl3) δ 149.4, 149.2, 148.1, 134.7, 133.8, 129.2, 127.9, 123.6,
75.3, 75.4, 62.1, 61.9, −2.7, −2.7; HRMS (ES+) calcd for
C16H19NOSi 269.1236. Found 269.1293.
(E)-tert-Butyl 2-(3-(dimethyl(phenyl)silyl)-1-hydroxyallyl)-1H-
pyrrole-1-carboxylate (2p). The title compound was prepared
according to general procedure A, from tert-butyl 2-(1-hydroxy-
prop-2-yn-1-yl)-1H-pyrrole-1-carboxylate72 1p (302 mg,
1.34 mmol) and dimethylphenylsilane (200 mg, 1.47 mmol)
using PtCl2 (3.6 mg, 13.4 μmol) and XPhos (18.4 mg,
0.027 mmol) in THF (1.5 mL) which following the conversion
to the vinyl silane and column chromatography (9 : 1 hexane–
EtOAc) aﬀorded 2r (297 mg, 61%) as a yellow oil.
Rf (9 : 1 hexane–EtOAc) = 0.49; νmax (thin film)/cm
−1; 3466,
3068, 2979, 2900, 1724, 1617, 1478, 1427, 1408, 1371, 1342,
1248, 1229, 1162, 1124, 1064, 998, 884, 821, 728, 700; 1H NMR:
(400 MHz, CDCl3) δ 7.53 (2H, m), 7.47–7.44 (2H, m), 7.35–7.30
(2H, m), 7.17 (1H, m), 6.40–6.34 (1H, dd, J = 18.6, 4.3 Hz), 6.13
(1H, d, J = 7.8 Hz), 6.10 (1H, d, J = 3 Hz), 6.03–5.99 (1H, m),
1.57 (9H, d, J = 11.5 Hz), 0.36 (6H, s); 13C NMR (100 MHz,
CDCl3) δ 146.9, 136.2, 134.1, 128.9, 127.9, 127.6, 122.3, 114.7,
113.4, 110.3, 110.1, 84.8, 69.8, 69.0, 27.9, −2.3; HRMS (EI+)
calcd for C16H16Si 236.1021. Found 236.1025.
(E)-3-(Dimethyl(phenyl)silyl)-1-(1,3-diphenyl-1H-pyrazol-4-yl)
prop-2-en-1-ol (2q). The title compound was prepared accord-
ing to general procedure A, from 1-(1,3-diphenyl-1H-pyrazol-4-
yl)prop-2-yn-1-ol 1q (275 mg, 1.01 mmol) and dimethylphenyl-
silane (150 mg, 1.11 mmol) using PtCl2 (2.7 mg, 0.011 mmol)
and XPhos (9.6 mg, 0.020 mmol) in THF (2 mL) which follow-
ing conversion to the vinyl silane and column chromatography
(19 : 1 hexane–EtOAc) aﬀorded 2q (290 mg, 71%) as a colour-
less oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.26; IR: νmax (thin film)/
cm−1; 3402, 2953, 1600, 1503, 1426, 1355, 1248, 1113, 1060,
820, 773, 756, 698; 1H NMR: (400 MHz, CDCl3) δ 7.87 (2H, d,
J = 5.0 Hz), 7.83–7.80 (1H, m), 7.77–7.69 (2H, m), 7.61–7.57 (1H,
m), 7.83–7.80 (1H, m), 7.50–7.27 (7H, m), 7.20 (2H, m), 6.37
(1H, dd, J = 18.5, 4.8 Hz), 6.18 (1H, dd, J = 18.5, 1.25 Hz), 5.42
(1H, s), 0.35 (6H, s); 13C NMR (100 MHz, CDCl3) δ 151.6, 148.1,
140.0, 139.9, 138.8, 133.8, 133.2, 133.0, 129.4, 129.2, 128.9,
128.6, 128.3, 127.8, 126.4, 125.7, 124.6, 119.0, 68.6, −2.5, −2.7;
HRMS (ES) calcd for C26H27N2OSi [M + H]
+ 256.1647. Found
411.1873.
General procedure B: hydrosilylation of disubstituted
propargyl alcohols
To an oven dried 5 mL round bottom flask equipped with a
reflux condenser and a magnetic stirrer was added PtCl2
(0.5 mol%) and 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbi-
phenyl (1 mol%) (XPhos). The flask was then flushed quickly
with argon and dry THF was added. The mixture was then
stirred at 50 °C for 20 minutes until a yellow homogeneous
mixture was obtained. The corresponding propargyl alcohol
(1 eq.) was added followed by the silane (1.1 eq.) via syringe
(CAUTION: Rapid evolution of hydrogen gas) and the solution
was stirred at 50 °C overnight. The solvent was evaporated and
the crude mixture was applied to the top of a column and chro-
matographed to aﬀord the requisite (E)-vinyl silane.
(E)-1-(Dimethyl(phenyl)silyl)-4-methyl-3-phenylpent-1-en-3-
ol (4e). The title compound was prepared according to general
procedure B, from 4-methyl-3-phenylpent-1-yn-3-ol73 3e
(104 mg, 0.601 mmol) and dimethylphenylsilane (89.9 mg,
0.661 mmol) using PtCl2 (1.8 mg, 6.61 μmol) and XPhos
(5.8 mg, 12.2 μmol) in THF (2 mL) which following the conver-
sion to the vinyl silane and column chromatography
(19 : 1 hexane–EtOAc) aﬀorded 4e (154 mg, 83%) as a colour-
less oil.
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Rf (9 : 1 hexane–EtOAc) = 0.39; νmax (thin film)/cm
−1; 3479,
3068, 3023, 2960, 1685, 1446, 1427, 1254, 1118, 1048, 998, 832,
795, 729, 699, 469; 1H NMR: (400 MHz, CDCl3) δ 7.98 (1H, d,
J = 7.0), 7.55–7.51 (2H, m), 7.50–7.46 (1H, m), 7.44 (2H, d, J =
7.8), 7.39–7.29 (4H, m), 6.53 (1H, dd, J = 18.6 Hz), 6.10 (1H, d,
J = 18.8 Hz), 2.24–2.17 (1H, dq, J = 13, 6.8 Hz), 0.90 (6H, d, J =
6.8 Hz), 0.35 (3H, s) 13C NMR (100 MHz, CDCl3) δ 151.5, 144.7,
133.0, 132.7, 132.2, 128.4, 128.2, 127.2, 126.7, 125.2, 124.6,
79.2, 78.9, 16.3, 15.9, −3.2; HRMS (ES+) calcd for C20H26ONaSi
[M + Na]+ 333.1651. Found 333.1573.
(E)-4-(Dimethyl(phenyl)silyl)-1,1,1-trifluoro-2-phenylbut-3-
en-2-ol (4g). The title compound was prepared according to
general procedure B, from 1,1,1-trifluoro-2-phenylbut-3-yn-2-ol
3g (273 mg, 1.37 mmol) and dimethylphenylsilane
(205 mg, 1.51 mmol) using PtCl2 (3.6 mg, 13.7 μmol) and
XPhos (13.3 mg, 0.028 mmol) in THF (2 mL) which
following the conversion to the vinyl silane and column
chromatography (9 : 1 hexane–EtOAc) aﬀorded 4g (369 mg,
80%) as a yellow oil.
Rf (9 : 1 hexane–EtOAc) = 0.41; νmax (thin film)/cm
−1; 3546,
3070, 2958, 1958, 18883, 1602, 1497, 1450, 1428, 1214, 11163,
1115, 997, 938, 844, 825, 761, 734, 699, 647; 1H NMR:
(400 MHz, CDCl3) δ 7.56 (2H, d, J = 8.0 Hz), 7.50–7.46 (2H, m),
7.42–7.33 (6H, m), 6.63 (1H, d, J = 18.8 Hz), 6.42 (1H, d, J =
18.8 Hz), 0.38 (6H, s) 13C NMR (100 MHz, CDCl3) δ 143.3,
137.1, 133.8, 133.5, 131.6, 129.4, 128.7, 128.3, 128.0, 127.9,
126.7 (t, 2JC–F = 223 Hz), 7.4, −2.8, −2.8; HRMS (ES+) calcd for
C18H18OF3Si [M − H+]+ 335.1079. Found 335.1081.
(E)-4-(Dimethyl(phenyl)silyl)-2-(thiophen-3-yl)but-3-en-2-ol
(4h). The title compound was prepared according to general
procedure B, from 2-(thiophen-3-yl)but-3-yn-2-ol 3h (176 mg,
0.761 mmol) and dimethylphenylsilane (89.9 mg, 0.662 mmol)
using PtCl2 (2.0 mg, 7.61 μmol) and XPhos (7.2 mg,
0.0152 mmol) in THF (2 mL) which following the conversion
to the vinyl silane and column chromatography (19 : 1 hexane–
EtOAc) aﬀorded 4h (202 mg, 92%) as a yellow oil.
Rf (9 : 1 hexane–EtOAc) = 0.39; νmax (thin film)/cm
−1; 3399,
3068, 2956, 1617, 1427, 1248, 1114, 991, 844, 827, 730. 698,
644; 1H NMR: (400 MHz, CDCl3) δ 7.52 (2H, dd, J = 5.5, 2.0
Hz), 7.40–7.32 (4H, m), 6.96–6.93 (2H, m), 6.42 (1H, d, J = 18.2
Hz), 6.13 (1H, d, J = 18.2 Hz), 1.72 (3H, s), 0.35 (6H, s) 13C
NMR (100 MHz, CDCl3) δ 152.4, 138.3, 133.8, 133.6, 128.9,
127.8, 126.7, 124.7, 124.4, 123.3, 74.2, 30.1, 9.7, −2.6; HRMS
(ES+) calcd for C16H21OSSi [M + H
+]+ 289.1082. Found
289.1112.
(E)-1-(2-(Dimethyl(phenyl)silyl)vinyl)cyclobutanol (4i). The
title compound was prepared according to general procedure
B, from 1-ethynylcyclobutan-1-ol 3i74 (133 mg, 1.38 mmol) and
dimethylphenylsilane (207 mg, 1.52 mmol) using PtCl2
(1.9 mg, 6.95 μmol) and XPhos (6.7 mg, 0.014 mmol) in THF
(1.5 mL) which following conversion to the vinyl silane and
column chromatography (19 : 1 hexane–EtOAc) aﬀorded 4i
(287 mg, 88%) as a colourless oil.
Rf (9 : 1 hexane–EtOAc) = 0.40; νmax (thin film)/cm
−1; 3329,
3068, 3049, 2984, 2956, 1616, 1427, 1248, 1169, 1114, 991, 844,
826, 729, 698; 1H NMR: (400 MHz, CDCl3) δ 7.54–7.47 (2H, m),
7.40–7.31 (3H, m), 6.38 (1H, d, J = 18.2 Hz), 5.98 (1H, d, J =
18.2 Hz), 1.72 (2H, s), 2.24–2.10 (1H, m), 2.00–1.92 (1H, m),
1.83–1.76 (1H, m), 1.65–1.52 (2H, m), 0.37 (6H, s) 13C NMR
(100 MHz, CDCl3) δ 151.6, 138.7, 133.8, 133.0, 129.0, 127.9,
122.7, 36.1, −2.4, −3.2; HRMS (ES+) calcd for C14H20NaOSi
[M + Na+]+ 255.3833. Found 255.3819.
(E)-1-(2-(Dimethyl(phenyl)silyl)vinyl)cycloheptanol (4j). The
title compound was prepared according to general procedure B,
from 1-ethynylcycloheptan-1-ol 3l75 (360 mg, 2.62 mmol) and
dimethylphenylsilane (389 mg, 2.86 mmol) using PtCl2
(3.5 mg, 0.013 mmol) and XPhos (12.4 mg, 0.026 mmol) in
THF (2 mL) which following conversion to the vinyl silane and
column chromatography (19 : 1 hexane–EtOAc) aﬀorded 4l
(562 mg, 79%) as a colourless oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.48; IR: νmax (thin film)/
cm−1; 3372, 3068, 2925, 1616, 1459, 1427, 1246, 1113, 1027,
993, 822, 731, 698; 1H NMR: (400 MHz, CDCl3) δ 7.53–7.50
(2H, m), 7.38–7.34 (3H, m), 6.28 (1H, d, J = 20 Hz), 5.96 (1H, d,
J = 20 Hz), 1.79–1.40 (12H, m), 0.36 (6H, s); 13C NMR
(100 MHz, CDCl3) δ 158.3, 136.3, 131.4, 130.2, 123.9, 43.5,
33.4, 32.3, 31.9, 24.9, 24.7, −2.5; HRMS (ES) calcd for
C17H26OSiNa [M + Na]
+ 297.1651. Found 297.1620.
(E)-1-(2-(Dimethyl(phenyl)silyl)vinyl)cyclooctanol (4m). The
title compound was prepared according to general procedure B,
from 1-ethynylcyclooctan-1-ol 3m75 (201 mg, 1.32 mmol) and
dimethylphenylsilane (0.22 mL, 1.45 mmol) using PtCl2
(1.8 mg, 6.60 μmol) and XPhos (6.2 mg, 0.0130 mmol) in THF
(2 mL) which following conversion to the vinyl silane and
column chromatography (9 : 1 hexane–EtOAc) aﬀorded 4m
(303 mg, 80%) as a colourless oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.41; IR: νmax (thin film)/
cm−1; 3362, 3068, 2922, 2854, 1613, 1470, 1446, 1427, 1264,
1246, 1113, 1064, 994, 843, 828, 733, 698, 642; 1H NMR:
(400 MHz, CDCl3) δ 7.52–7.49 (2H, m), 7.36–7.33 (3H, m), 6.27
(1H, d, J = 18.8 Hz), 5.97 (1H, d, J = 18.8 Hz), 1.80–1.60 (9H,
m), 1.57–1.41 (5H, m), 0.34 (6H, s); 13C NMR (100 MHz, CDCl3)
δ 157.6, 141.4, 136.2, 135.4, 131.3, 130.2, 125.4, 78.5, 38.7,
30.7, 27.1, 24.5, 2.4, −0.27, −0.71; HRMS (ES) calcd for
C8H28OSiNa [M + Na]
+ 311.1807. Found 311.1787.
(E)-1-(2-(Dimethyl(phenyl)silyl)vinyl)cyclododecanol (4n). The
title compound was prepared according to general procedure
B, from 1-ethynylcyclododecan-1-ol 3n76 (188 mg, 0.901 mmol)
and dimethylphenylsilane (135 mg, 0.099 mmol) using PtCl2
(1.2 mg, 4.52 μmol) and XPhos (4.3 mg, 9.04 μmol) in THF
(2 mL) which following conversion to the vinyl silane and
column chromatography (9 : 1 hexane–EtOAc) aﬀorded 4n
(285 mg, 91%) as a yellow oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.46; IR: νmax (thin film)/
cm−1; 3364, 3070, 2940, 2848, 1615, 1469, 1427, 1246, 1114,
994, 844, 823, 730, 698; 1H NMR: (400 MHz, CDCl3) δ
7.53–7.49 (2H, m), 7.36–7.34 (3H, m), 6.24 (1H, d, J = 18.8 Hz),
5.97 (1H, d, J = 18.8 Hz), 1.66–1.58 (2H, m), 1.53–1.42 (5H, m),
1.40–1.32 (18H, m), 0.34 (6H, s); 13C NMR (100 MHz, CDCl3) δ
157.0, 141.3, 136.3, 131.3, 130.1, 125.4, 78.7, 37.1, 28.9, 28.4,
25.0, 24.6, 22.1, 2.5, 0.3, −0.3; HRMS (ES) calcd for C22H35OSi
[M − H+]+ 343.2457. Found 343.2454.
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(E)-1-(2-(Dimethyl(phenyl)silyl)vinyl)-4,4-difluorocyclohexa-
nol (4o). The title compound was prepared according to
general procedure B, from 1-ethynyl-4,4,-difluorocyclohexan-1-
ol 3o (98 mg, 0.605 mmol) and dimethylphenylsilane
(90.4 mg, 0.665 mmol) using PtCl2 (0.9 mg, 3.2 μmol) and
XPhos (3.1 mg, 6.4 μmol) in THF (1 mL) which following con-
version to the vinyl silane and column chromatography
(9 : 1 hexane–EtOAc) aﬀorded 4o (136 mg, 76%) as a colourless
oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.43; IR: νmax (thin film)/
cm−1; 3419, 3069, 2953, 1700, 1618, 1443, 1427, 1377, 1358,
1250, 1117, 1113, 991, 844, 825, 721, 700, 667; 1H NMR:
(400 MHz, CDCl3) δ 7.51–7.48 (2H, m), 7.40–7.33 (3H, m), 6.28
(1H, d, J = 18.8 Hz), 5.96 (1H, d, J = 18.8 Hz), 2.16–2.07 (4H,
m), 1.86–1.76 (2H, m), 1.70–1.61 (2H, m) 0.35 (6H, s); 13C NMR
(100 MHz, CDCl3) δ 153.4, 133.9, 133.5, 129.1, 129.0, 127.9 (t,
1JC–F = 241.6 Hz), 127.8, 33.8, 33.7, −2.4, −3.6; HRMS (ES)
calcd for C16H21F2OSi [M − H+]+ 295.1337. Found 295.1330.
(E)-8-(2-(Dimethyl(phenyl)silyl)vinyl)-1,4-dioxaspiro[4.5]-
decan-8-ol (4p). The title compound was prepared according
to general procedure B, from 8-ethynyl-1,4-dioxaspiro[4.5]
decan-8-ol 3p77 (195 mg, 1.07 mmol) and dimethylphenylsi-
lane (160 mg, 1.18 mmol) using PtCl2 (1.2 mg, 5.4 μmol) and
XPhos (5.2 mg, 0.011 mmol) in THF (1.5 mL) which following
the conversion to the vinyl silane and column chromatography
(9 : 1 hexane–EtOAc) aﬀorded 4p (240 mg, 64%) as a yellow oil.
Rf (4 : 1 hexane–ethyl acetate) = 0.41; IR: νmax (thin film)/
cm−1; 3444, 2922, 2854, 1640, 1397, 1268, 1248, 1102, 845, 749;
1H NMR: (400 MHz, CDCl3) δ 7.51–7.48 (2H, m), 7.36–7.32 (3H,
m), 6.21 (1H, dd, J = 18.8, 5.8 Hz), 6.03 (1H, d, J = 18.8 Hz),
4.03, (1H, s), 3.95 (4H, ddd, J = 5.5, 3.5, 1.7 Hz), 2.03–1.79 (4H,
m), 1.65–1.57 (4H, m), 0.34 (6H, s); 13C NMR (100 MHz, CDCl3)
δ 154.5, 138.5, 133.8, 129.1, 127.8, 123.7, 108.5, 71.9, 64.3,
64.2, 34.9, 30.4, −2.5; HRMS (ES) calcd for C18H30NO3Si
[M + NH4]
+ 336.1995. Found 336.1996.
(E)-2-(2-(Dimethyl(phenyl)silyl)vinyl)-1,2,3,4-tetrahydronaphtha-
len-2-ol (4q). The title compound was prepared according to
general procedure B, from 2-ethynyl-1,2,3,4-tetrahydronaphtha-
len-2-ol 3q (35.2 mg, 0.204 mmol) and dimethylphenylsilane
(30.6 mg, 0.225 mmol) using PtCl2 (0.3 mg, 1.02 μmol) and
XPhos (1.0 mg, 2.02 μmol) in THF (1 mL) which following the
conversion to the vinyl silane and column chromatography
(19 : 1 hexane–EtOAc) aﬀorded 4q (47 mg, 77%) as a yellow oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.26;
1H NMR: (400 MHz,
CDCl3) δ 7.53–7.47 (2H, m), 7.40–7.35 (3H, m), 7.17 (3H, m),
7.10 (1H, m), 6.31 (1H, dd, J = 18.8 Hz), 6.12 (1H, d, J = 18.8
Hz), 2.84–2.78 (2H, m), 2.21 (2H, m), 2.07–1.88 (2H, ddddd, J =
18.1, 12.3, 7.8, 6.0, 5.8 Hz), 0.35 (6H, s); 13C NMR (100 MHz,
CDCl3) δ 156.2, 136.3, 131.5, 131.4, 130.6, 130.2, 130.0, 128.8,
127.1, 76.7, 40.1, 32.4, 32.2, 21.7, 12.2, 0.1, −0.6, −0.9; HRMS
(ES) calcd for C20H25OSi [M + H]
+ 309.1675. Found 309.1678.
(E)-3-(2-(Dimethyl(phenyl)silyl)vinyl)-2,3,4,9-tetrahydro-1H-
carbazol-3-ol (4r). The title compound was prepared according
to general procedure B, from 3-ethynyl-2,3,4,9-tetrahydro-1H-
carbazol-3-ol 3r78 (43.7 mg, 0.208 mmol) and dimethylphenyl-
silane (31.1 mg, 0.228 mmol) using PtCl2 (0.6 mg, 2.08 μmol)
and XPhos (2.0 mg, 4.16 μmol) in THF (1 mL) which following
the conversion to the vinyl silane and column chromatography
(4 : 1 hexane–EtOAc) aﬀorded 4r (55 mg, 76%) as a colourless
solid.
Rf (4 : 1 hexane–ethyl acetate) = 0.35; IR: νmax (thin film)/
cm−1; 3402, 3284, 2340, 2275, 1704, 1667, 1604, 1468, 1329,
1052, 962, 748, 667; 1H NMR: (400 MHz, CDCl3) δ 7.76 (1H, s),
7.55–7.49 (2H, d, J = 6.0, 3.6 Hz), 7.44–7.33 (3H, m), 7.25 (1H,
m), 7.15–7.14 (2Hm), 6.37 (1H, d, J = 18.7 Hz), 6.17 (1H, d, J =
18.7 Hz), 2.95 (2H, d, J = 15.6 Hz), 2.88–2.70 (2H, dd, J = 14.4,
3.9 Hz), 2.04–1.87 (2H, m), 0.34 (6H, s); 13C NMR (100 MHz,
CDCl3) δ153.0, 138.3, 136.0, 133.4, 132.2, 128.6, 127.5, 127.5,
124.3, 121.1, 118.9, 117.4, 110.0, 106.9, 76.9, 72.2, 34.1, 33.7,
19.7, −3.0; HRMS (ES) calcd for C22H26NOSi [M + H]+
348.1784. Found 348.1778.
(E)-tert-Butyl-3-(2-(dimethyl(phenyl)silyl)vinyl)-3-hydroxyaze-
tidine-1-carboxylate (4s). The title compound was prepared
according to general procedure B, from tert-butyl 3-ethynyl-3-
hydroxyazetidine-1-carboxylate 3s79 (135 mg, 0.685 mmol) and
dimethylphenylsilane (102 mg, 0.753 mmol) using PtCl2
(0.9 mg, 3.43 μmol) and XPhos (3.3 mg, 6.85 μmol) in THF
(1.5 mL) which following the conversion to the vinyl silane and
column chromatography (9 : 1 hexane–EtOAc) aﬀorded 4s
(163 mg, 72%) as a yellow oil.
Rf (4 : 1 hexane–ethyl acetate) = 0.21; IR: νmax (thin film)/
cm−1; 2977, 2881, 1679, 1427, 1367, 1248, 1158, 1114, 825, 764,
699, 667; 1H NMR: (400 MHz, CDCl3) δ 7.53–7.47 (2H, m),
7.40–7.35 (3H, m), 6.36 (1H, dd, J = 18.8 Hz), 6.12 (1H, d, J =
18.8 Hz), 3.98 (1H, d, J = 9.3 Hz), 3.92 (1H, d, J = 9.3 Hz), 1.44
(9H, s), 0.38 (6H, s); 13C NMR (100 MHz, CDCl3) δ 156.5, 148.5,
137.7, 128.9, 127.9, 127.8, 126.5, 79.8, 70.6, 62.3, 28.4, −2.8;
HRMS (ES) calcd for C18H27NO3SiNa [M + NH4]
+ 356.1658.
Found 356.1661.
(E)-3-(2-(Dimethyl(phenyl)silyl)vinyl)-8-methyl-8-azabicyclo-
[3.2.1]octan-3-ol (4u). The title compound was prepared
according to general procedure B, from 3-ethynyl-8-methyl-8-
azabicyclo[3.2.1]octan-3-ol 3u (78 mg, 0.472 mmol) and
dimethylphenylsilane (70.2 mg, 0.520 mmol) using PtCl2
(0.6 mg, 2.36 μmol) and XPhos (2.2 mg, 4.7 μmol) in THF
(1.5 mL) which following conversion to the vinyl silane and
column chromatography (SCX-2 ion exchange resin) aﬀorded
4u (82.7 mg, 59%) as a yellow oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.35; IR: νmax (thin film)/
cm−1; 3435, 3069, 2957, 1656, 1639, 1427, 1253, 1119, 1054,
1027, 998, 830, 789, 725, 698, 649; 1H NMR: (400 MHz, CDCl3)
δ 7.54–7.44 (2H, m), 7.38–7.31 (3H, m), 6.06 (1H, d, J = 18.8 Hz),
5.90 (1H, d, J = 18.8 Hz), 2.51 (1H, s), 2.30–2.27 (3H, d, J =
7.4 Hz), 2.20–2.11 (3H, m), 2.07–1.90 (6 H, m), 0.33 (6H, s); 13C
NMR (100 MHz, CDCl3) δ 157.0, 141.2, 136.3, 132.1, 130.1,
125.3, 37.2, 28.9, 25.0, 24.4, 22.0, −0.69; HRMS (ES) calcd for
C16H24NOSi [M − CH3]+ 286.1627. Found 286.1661.
(E)-4-(2-(Dimethyl(phenyl)silyl)vinyl)tetrahydro-2H-thiopyran-
4-ol (4w). The title compound was prepared according to
general procedure B, from 4-ethynyl-tetrahydro-2H-thiopyran-4-
ol 3w (107 mg, 0.760 mmol) and dimethylphenylsilane
(113 mg, 0.836 mmol) using PtCl2 (1.0 mg, 3.80 μmol) and
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XPhos (3.6 mg, 7.60 μmol) in THF (2 mL) which following con-
version to the vinyl silane and column chromatography
(9 : 1 hexane–EtOAc) aﬀorded 4w (173 mg, 82%) as a yellow oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.43; IR: νmax (thin film)/
cm−1; 3426, 2922, 2854, 1640, 1397, 1268, 1247, 1113, 849, 825,
748, 699; 1H NMR: (400 MHz, CDCl3) δ 7.49 (2H, m), 7.41–7.33
(3H, m), 6.15 (1H, d, J = 18.8 Hz), 6.00 (1H, d, J = 18.8 Hz),
3.06–2.97 (4H, ddd, J = 10.3, 4.0, 3.8 Hz), 1.86–1.80 (4H, ddd,
J = 13.5, 3.5, 1.8 Hz), 0.39 (6H, s); 13C NMR (100 MHz, CDCl3) δ
154.4, 138.4, 133.8, 132.9. 129.7, 129.1, 127.8, 115.3, 71.3, 38.0,
24.0, −2.6; HRMS (ES) calcd for C15H2721OSSi [M − H]+
277.1082. Found 277.1062.
(E)-4-(tert-Butyldimethylsilyl)-2-methylbut-3-en-2-ol (5c). The
title compound was prepared according to general procedure
B, from 2-methyl-3-butyn-2-ol 3a (97.0 μL, 1.00 mmol) and tert-
butyldimethyl silane (0.18 mL, 1.1 mmol) using PtCl2 (1.3 mg,
5.00 μmol) and XPhos (4.8 mg, 10.00 μmol) in THF (1 mL)
which following conversion to the vinyl silane and column
chromatography (19 : 1 hexane–EtOAc) aﬀorded 5c (173 mg,
84%) as a yellow oil.
Rf (9 : 1 hexane–ethyl acetate) = 0.76; IR: νmax (thin film)/
cm−1; 3362, 2953, 2928, 2856, 1616, 1470, 1361, 1390, 1247,
1147, 963, 908, 830; 1H NMR: (400 MHz, CDCl3) δ 6.18 (1H, d,
J = 18.8 Hz), 5.84 (1H, d, J = 18.8 Hz), 1.31 (6H, s), 0.88 (9H, s),
0.04 (6H, s); 13C NMR (100 MHz, CDCl3) δ 154.6, 121.8, 72.1,
29.5, 26.4, 16.6, −6.14; HRMS (ES) calcd for C11H24NaOSi [M +
Na]+ 223.1494. Found 223.1397.
(E)-4-(Benzyldimethylsilyl)-2-methylbut-3-en-2-ol (5f). The
title compound was prepared according to general procedure
B, from 2-methyl-3-butyn-2-ol 3a (300 mg, 3.57 mmol) and
dimethylbenzylsilane (803 mg, 3.93 mmol) using PtCl2
(4.8 mg, 0.018 mmol) and XPhos (17.1 mg, 0.036 mmol) in
THF (1.5 mL) which following conversion to the vinyl silane
and column chromatography (9 : 1 hexane–EtOAc) aﬀorded 5f
(808 mg, 97%) as a colourless oil.
Rf (9 : 1 hexane–EtOAc) = 0.45; IR: νmax (thin film)/cm
−1; 3496,
2900, 2655, 1644, 1066, 978; 1H NMR: (400 MHz, CDCl3) δ
7.24–7.17 (2H, m), 7.10–7.04 (1H, m), 7.01–6.97 (2H, m), 6.09 (1H,
d, J = 19.1 Hz), 5.77 (1H, d, J = 19.1 Hz), 2.15 (2H, s), 1.42 (1H, s),
1.29 (6H, s), 0.06 (6H, s); 13C NMR (100 MHz, CDCl3) δ 154.5,
139.9, 128.3, 128.0, 124.0, 122.6, 74.0, 30.9, 29.3, 26.1, −3.4; HRMS
(ES) calcd for C14H23OSi [M + H]
+ 235.1518. Found 235.1528.
1-(2H)-Ethynyl-1-cyclohexanol (23). 1-Ethynyl-1-cyclohexanol
(270 mg, 2.18 mmol) was added to an oven dried round
bottom flask and placed under argon. Dry THF (4.5 mL) was
added to this and the temperature was lowered to −78 °C.
n-Butyl lithium (2.5 M) (1.04 mL, 2.61 mmol) was added slowly
and the reaction mixture was allowed to stir at this temperature
for 1.5 hours. The reaction mixture was quenched with D2O,
extracted with dry Et2O and dried over Na2SO4. The solvent
was removed under reduced pressure and the deuterated
product was used without any further purification. Product
was obtained (200 mg, 74%, 86% deuterium incorporation as
determined by 1H NMR) as a colourless oil. 1H NMR:
(400 MHz, CDCl3) δ 2.48 (0.15H, s), 1.99, (1H, s), 1.96–1.83 (2 H,
m), 1.77–1.48 (6H, m), 1.33–1.66 (1H, m).
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